Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good to know.
Just on the sideline
sold this turd yesterday 0.92s
PR and price drops
need a pr from the company
European patent GRANTED!
https://register.epo.org/application?number=EP16721208
Thank you so much and good luck$$$
TCBP has had so many price spikes over the month few months it has been a profitable trade to buy after weakness, I have a full position currently.
Do you think it’s time to buy? I am new here
https://stockcharts.com/h-sc/ui?s=tcbp&p=D&yr=0&mn=6&dy=0&id=p38090673899
https://www.barchart.com/stocks/quotes/tcbp/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100
https://www.barchart.com/stocks/quotes/tcbp/opinion
https://finance.yahoo.com/quote/tcbp/
Bottom bounce coming!
TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies
TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies
TCBP: But, nobody interested --- whatever works.
https://stockcharts.com/h-sc/ui?s=tcbp&p=D&yr=0&mn=6&dy=0&id=p38090673899
https://www.barchart.com/stocks/quotes/tcbp/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100
https://www.barchart.com/stocks/quotes/tcbp/opinion
https://finance.yahoo.com/quote/tcbp/
Chart bounce candidate!
$TCBP The acceptance of TC BioPharm’s amendment by the MHRA for the ACHIEVE UK trial can be seen as a bullish signal for several reasons:
1. Enhanced Trial Flexibility: The ability to increase the dose level for TCB008 and shift to an outpatient procedure may improve the trial’s efficiency and patient experience. This flexibility could potentially lead to better trial outcomes and patient adherence.
2. Operational Efficiency: Reducing the need for overnight hospital stays for patients after dosing not only improves the quality of life for participants but also eases the burden on clinical sites. This operational efficiency can accelerate the trial’s progress.
3. Positive Regulatory Feedback: Gaining regulatory acceptance for amendments suggests a positive interaction between TC BioPharm and regulatory bodies, indicating that the company is responsive and adaptable to both regulatory requirements and clinical insights.
4. Potential Impact on FDA Trial: The amendments align with the dosing levels of the Investigational New Drug (IND) application for the second cohort, which might streamline the process for the FDA trial. This proactive approach to aligning international trial standards may facilitate smoother regulatory negotiations and trial implementations in multiple jurisdictions.
5. Innovative Treatment Potential: The focus on TCB008 and its application in treating Acute Myeloid Leukemia (AML) underscores TC BioPharm’s commitment to developing innovative cancer treatments. Success in these trials could position the company as a leader in gamma-delta T cell therapies, potentially opening up significant market opportunities.
TCBP..................................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783
Looking better $1.80s premarket and warrants should be out of way next push.
"Series E Warrants") to purchase up to 1,750,000 of its ADSs at a public offering price of $2.00 per ADS (or pre-funded warrant in lieu thereof) and associated Series
CORRECTION: I found out he was trying to get Dave Portnoys attention, thats why he kept tagging him in his posts
not that Dave from BAR STOOLS has anything to do with or even a shareholder of TCBP
this guy is claiming the Dave Portnoy gave this pick @ .90?
Im still trying to figure it out
https://twitter.com/professorDman1/status/1755742921595257071
https://twitter.com/professorDman1/status/1755754655060000836
https://twitter.com/professorDman1/status/1755734122725597243
https://stockcharts.com/h-sc/ui?s=tcbp&p=D&yr=0&mn=6&dy=0&id=p38090673899
https://www.barchart.com/stocks/quotes/tcbp/technical-chart?plot=CANDLE&volume=total&data=DO&density=M&pricesOn=1&asPctChange=0&logscale=1&indicators=BBANDS(20,2);SMA(13);PTP(50);ADX(14);SMA(50);SMACD(12,26,9);RSI(14,100);ACCUM;STOSL(14,3)&sym=CNNA&grid=1&height=500&studyheight=100
https://www.barchart.com/stocks/quotes/tcbp/opinion
https://finance.yahoo.com/quote/tcbp/
Looking for a bottom in TCBP!
TCBP............................https://stockcharts.com/h-sc/ui?s=TCBP&p=W&b=5&g=0&id=p86431144783
Sold later in afternoon at $3.16. Will wait unti after the coming RS.
Started a position today (1-2-24) in TCBP at $3.08. With a market cap of just 2.4 million and only 752 thousand shares outstanding, figure it is worth a shot.
1/18/2023, 1:55:43 PMPre-funded warrants likely all exercised and sold already. Current float closer to 2m.
https://dilutiontracker.com/app/search/TCBP?a=dbb88c
They dumped very hard on news
Yes they are. No doubts here. IND application approval decision was due yesterday. News any day. Most likely Monday morning.
Their gonna miss a HUGE RUN!!
I see this board still sleeping on TCBP with IND application approval pending for AML patients who are refractory/relapse .
Followers
|
18
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
606
|
Created
|
03/02/22
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads